Explanipedia

Le TNM : la 9e édition pour l'oncologie thoracique Open

Apostolos C. Agrafiotis, Bogdan Grigoriu, Paul Van Schil · 2025

Comment optimiser le bilan d’opérabilité ? Open

Pierre‐Emmanuel Falcoz, Thierry Berghmans, Mariana Brandão, Bogdan Grigoriu, Anne Charloux · 2024

Comment optimiser le bilan d’opérabilité ? Open

Thierry Berghmans, Mariana Brandão, Bogdan Grigoriu, Anne Charloux · 2023

Supplementary Tables 1-3, Figures 1-6 from Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non–Small Cell Lung Cancer Patients (SAKK 19/05 trial) Open

Anca Franzini, Florent Baty, Ina I. Macovei, Oliver Dürr, C. Droege , et al. · 2023

Supplementary Tables 1-3, Figures 1-6. Supplementary Table 1: Statistical analysis of differences between the study group and the remaining group of patients for several variables. Supplementary Table 2: Primers used for the RT-qPCR assays…

Supplementary Tables 1-3, Figures 1-6 from Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non–Small Cell Lung Cancer Patients (SAKK 19/05 trial) Open

Anca Franzini, Florent Baty, Ina I. Macovei, Oliver Dürr, C. Droege , et al. · 2023

Supplementary Tables 1-3, Figures 1-6. Supplementary Table 1: Statistical analysis of differences between the study group and the remaining group of patients for several variables. Supplementary Table 2: Primers used for the RT-qPCR assays…

Data from Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non–Small Cell Lung Cancer Patients (SAKK 19/05 trial) Open

Anca Franzini, Florent Baty, Ina I. Macovei, Oliver Dürr, C. Droege , et al. · 2023

Purpose: We aimed to identify gene expression signatures associated with angiogenesis and hypoxia pathways with predictive value for treatment response to bevacizumab/erlotinib (BE) of nonsquamous advanced non–small cell lung cancer…

Data from Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non–Small Cell Lung Cancer Patients (SAKK 19/05 trial) Open

Anca Franzini, Florent Baty, Ina I. Macovei, Oliver Dürr, C. Droege , et al. · 2023

Purpose: We aimed to identify gene expression signatures associated with angiogenesis and hypoxia pathways with predictive value for treatment response to bevacizumab/erlotinib (BE) of nonsquamous advanced non–small cell lung cancer…

Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure Open

Maxence Hureau, Lucie Portier, Méline Prin, Patricia de Nadaı̈, Joanne Balsamelli , et al. · 2023

Background: Acute respiratory distress syndrome (ARDS) is a life-threatening condition resulting from acute pulmonary inflammation. However, no specific treatment for ARDS has yet been developed. Previous findings suggest that lung injurie…

European Respiratory Society guideline on various aspects of quality in lung cancer care Open

Torsten Blum, Rebecca L. Morgan, Valérie Durieux, Joanna Chorostowska‐Wynimko, David Baldwin , et al. · 2022

This European Respiratory Society guideline is dedicated to the provision of good quality recommendations in lung cancer care. All the clinical recommendations contained were based on a comprehensive systematic review and evidence synthese…

PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients Open

Candice Gueuning, Lieveke Ameye, Angela Loizidou, Bogdan Grigoriu, Anne‐Pascale Meert · 2022

Place de la réanimation après chirurgie thoracique Open

V. Fontana, Michelle Coureau, Bogdan Grigoriu, Nicola Tamburini, Jean Lemaitre , et al. · 2022

Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies Open

Thierry Berghmans, J. Cadranel, Bogdan Grigoriu · 2021

International audience

Trabectedin-Related Heart Failure: Case Report and a Systematic Review of the Literature Open

Julien Catherine, Christiane Jungels, Valérie Durieux, C. Deliens, Bogdan Grigoriu · 2021

New drugs come not only with benefits but also with unexpected toxicities which need to be promptly recognized and managed. Starting from a scholar case of acute heart failure with preserved ejection fraction following the administration o…

Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference Open

Anne‐Pascale Meert, Sebastian Wittnebel, Stéphane Holbrechts, Anne‐Claire Toffart, Jean‐Jacques Lafitte , et al. · 2021

Management of thymoma associated autoimmune pure red cell aplasia: Case report and systematic review of the literature Open

Bastien Lesire, Valérie Durieux, Bogdan Grigoriu, Nicolas Girard, Thierry Berghmans · 2021

The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus Open

Αrgyris Τzouvelekis, Katerina M. Antoniou, Michael Kreuter, Matthew Evison, Torsten Blum , et al. · 2020

Background Currently there is major lack of agreement on the diagnostic and therapeutic management of patients with idiopathic pulmonary fibrosis (IPF) and lung cancer. Our aim was to identify variations in diagnostic and management strate…

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders Open

Michelle Coureau, Anne‐Pascale Meert, Thierry Berghmans, Bogdan Grigoriu · 2020

Immunotherapy is an important armamentarium for cancer treatment nowadays. Apart from their significant effectiveness in controlling disease they also generate potential severe immune related adverse effects. Preexistence of immune related…

The DIAMORFOSIS (Diagnosis and Management of Lung Cancer and Fibrosis) Survey Open

A.E. Tzouvelekis, Katerina Antoniou, Michael Kreuter, Matthew Evison, Τheodoros Karampitsakos , et al. · 2020

Continuous professional development: elevating thoracic oncology education in Europe Open

Wouter H. van Geffen, Torsten Blum, Stefano Aliberti, Kevin G. Blyth, Clementine Bostantzoglou , et al. · 2019

The @EuroRespSoc launches a new thoracic oncology continuous professional development programme http://bit.ly/31ShuTp.

Endocan serum concentration in uninfected newborn infants Open

Gabriela Ildikó Zonda, Radu Zonda, Andrei Tudor Cernomaz, Luminița Păduraru, Bogdan Grigoriu · 2019

Introduction: Endocan is a specific endothelial mediator involved in the inflammatory response. Its role in the diagnosis of sepsis has been studied in adult patients and late onset neonatal sepsis. The clinical signs of early onset sepsis…

Transplantation pulmonaire des adénocarcinomes pulmonaires invasifs « lépidiques » : d’une question clinique à une réflexion éthique Open

Perrine Créquit, Jacques Cadranel, Hervé Mal, Bogdan Grigoriu, Thierry Berghmans · 2019

Endocan - a potential diagnostic marker for early onset sepsis in neonates Open

Gabriela Ildikó Zonda, Radu Zonda, Andrei Tudor Cernomaz, Luminița Păduraru, Andreea Avasiloaiei , et al. · 2019

Introduction: Neonatal early onset sepsis assessment is based on the history of pregnancy and delivery and nonspecific clinical signs. None of the biomarkers currently in use for clinical practice has adequate prognostic value, so it is no…

Paraneoplastic hypercortisolism : case report and review of available therapeutic options Open

Andrew Nguyen, Bogdan Grigoriu, A-P Meert · 2019

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries Open

Anna Rich, David Baldwin, Inmaculada Alfageme, Paul Beckett, Thierry Berghmans , et al. · 2018

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Open

Anna Rich, David Baldwin, Paul Beckett, Thierry Berghmans, Jeanette Boyd , et al. · 2018

The European Respiratory Society (ERS) task force for harmonised standards for lung cancer registration and lung cancer services in Europe recognised the need to create a single dataset for use in pan-European data collection and a manual …

Management of Acute Complications of Targeted Therapy in Patients With Cancer: A Review of Cases Managed in ICU Open

Aureliano Pistone, Valérie Durieux, Bogdan Grigoriu, Anne‐Pascale Meert · 2018

Introduction: Targeted therapies, molecules in full expansion, are not free of side effects that can lead patients to intensive care. We performed an extensive review of the published evidence and propose a management strategy for acute co…

Pain control in thoracic oncology Open

Christine Peeters-Asdourian, Gilbert Massard, Paragi Rana, Paul Van Houtte, Andrew P. White , et al. · 2017

This review of pain management in lung cancer is based on the presentation of four cases of thoracic oncology patients with pain at various stages of their disease. The approach will be multidisciplinary, involving a thoracic oncologist, r…

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles Open

Lucien Ruelle, Georgiana Pintea Bentea, Spyridon Sideris, Mohamed El Koulali, Stéphane Holbrechts , et al. · 2017

Intensive care in thoracic oncology Open

Anne‐Pascale Meert, Bogdan Grigoriu, Marc Licker, Paul Van Schil, Thierry Berghmans · 2017

The admission of lung cancer patients to intensive care is related to postprocedural/postoperative care and medical complications due to cancer or its treatment, but is also related to acute organ failure not directly related to cancer. De…

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology Open

Fernando Gamarra, Julie-Lyn Noël, Alessandro Brunelli, Anne‐Marie C. Dingemans, Enriqueta Felip , et al. · 2016

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology http://ow.ly/mdqT300NHqO.

Bogdan Grigoriu YOU? Author Swipe